Territory Stories

Overcoming indigenous disadvantage - key indicators

Details:

Title

Overcoming indigenous disadvantage - key indicators

Creator

Steering Committee for the Review of Government Service Provision

Collection

E-Publications; E-Books; PublicationNT

Date

2003-11

Description

The OID report measures the wellbeing of Aboriginal and Torres Strait Islander Australians, and Aboriginal and Torres Strait Islander Australians have been actively involved in the development and production of the report. Section 1.1 describes the origins of the report, and section 1.2 describes its key objectives. Section 1.3 provides contextual information on the Aboriginal and Torres Strait Islander population. Section 1.4 includes a brief historical narrative to help put the information in the report into context. Section 1.5 summarises some recent developments in government policy that have influenced the report and section 1.6 provides further information on the Steering Committee and the OID Working Group that advises it.

Notes

"These reports generally uses the term ‘Aboriginal and Torres Strait Islander Australians’ to describe Australia’s first peoples and ‘non-Indigenous Australians’ to refer to Australians of other backgrounds, except where quoting other sources." Aboriginal and Torres Strait Islander people should be aware that this publication may contain images of deceased people.

Table of contents

Preliminaries -- Overview chapter -- Introduction -- The framework -- Key themes and interpretation -- COAG targets and headline indicators -- Governance, leadership and culture -- Early child development -- Education and training -- Healthy lives -- Economic participation -- Home environment -- Safe and supportive communities -- Outcomes for Torres Strait Islander people -- Measuring factors that improve outcomes -- Appendices.

Language

English

Subject

Aboriginal Australians -- Ecoomic conditions; Aboriginal Australians -- Social conditions; Public welfare administration -- Australia; Aboriginal Australians -- Services for; Closing the Gap of Indigenous Disadvantage (Australia)

Publisher name

Australia. Productivity Commission for the Steering Committee for the Review of Government Service Provision

Place of publication

Canberra (A.C.T.)

Format

5 volumes (various pagings) : charts, colour map ; 30 cm.

File type

application/pdf

ISBN

9781740375917 (Print); 9781740375900 (PDF)

ISSN

1448-9805 (Print); 2206-9704 (Online)

Use

Copyright

Copyright owner

Australia. Productivity Commission for the Steering Committee for the Review of Government Service Provision

License

https://www.legislation.gov.au/Details/C2019C00042

Parent handle

https://hdl.handle.net/10070/267090

Citation address

https://hdl.handle.net/10070/445158

Related items

https://hdl.handle.net/10070/445153; https://hdl.handle.net/10070/445154; https://hdl.handle.net/10070/445156; https://hdl.handle.net/10070/445151

Page content

11.12 OVERCOMING INDIGENOUS DISADVANTAGE 2016 11.2 Drug and other substance use and harm3 Box 11.2.1 Key messages In 2014-15, around two-thirds (68.6 per cent) of Aboriginal and Torres Strait Islander adults reported not having used drugs in the previous 12 months (table 11A.2.1). The proportion of Aboriginal and Torres Strait Islander adults reporting illicit substance use in the previous 12 months increased from around 23 per cent in all earlier survey periods (2002, 2008 and 2012-13) to 30.8 per cent in 2014-15 (table 11A.2.1). This increase was driven by higher reported non-medical use of analgesics and sedatives, by both males (11.3 per cent) and females (14.5 per cent) (figure 11.2.1) and in non-remote areas (table 11A.2.3). Between 2004-05 and 2014-15, after adjusting for differences in population age structures, for NSW, Victoria, Queensland, WA, SA and the NT combined, rates of hospitalisation for Aboriginal and Torres Strait Islander Australians increased from 1.4 to 2.3 times the rate for other Australians for drug-related poisoning, and increased from 2.7 to 3.1 times the rate for drug-related mental/behavioural disorders (table 11A.2.10). For 20102014, after adjusting for differences in population age structures, for NSW, Queensland, WA, SA and the NT combined, the drug-induced death rate for Aboriginal and Torres Strait Islander Australians was 1.9 times the rate for non-Indigenous Australians (table 11A.2.14). In 2013-14, a smaller proportion of Aboriginal and Torres Strait Islander homicides had drug involvement (7 out of 24) than non-Indigenous homicides (53 out of 141) (table 11A.2.15). Box 11.2.2 Measures of drug and other substance use and harm There is one main measure for this indicator. Substance use is defined as the proportion of people aged 18 years and over who reported using illicit substances or misusing licit substances in the previous 12 months. Data are sourced from the ABS Australian Aboriginal and Torres Strait Islander Health Survey (AATSIHS)/National Aboriginal and Torres Strait Islander Social Survey (NATSISS), with the most recent available data for 2014-15 from the NATSISS (all jurisdictions; sex; age). Data are not available for non-Indigenous Australians or (for the 2004-05 survey) remote areas. Three supplementary measures are also reported by Indigenous status: Drug related hospitalisations (all jurisdictions; sex; remoteness) Drug induced deaths (NSW, Queensland, WA, SA and the NT; sex) Drug involvement in homicides (national). The misuse of legal drugs has major negative effects on individuals, families and communities (see section 11.1 Alcohol consumption and harm and section 8.4 Tobacco 3 The Steering Committee notes its appreciation to Dr Kyllie Cripps, University of NSW, who reviewed a draft of this section of the report.


Aboriginal and Torres Strait Islander people are advised that this website may contain the names, voices and images of people who have died, as well as other culturally sensitive content. Please be aware that some collection items may use outdated phrases or words which reflect the attitude of the creator at the time, and are now considered offensive.

We use temporary cookies on this site to provide functionality.
By continuing to use this site without changing your settings, you consent to our use of cookies.